B Braun’s full range of wound care products such as Askina Calgitrol Ag and Prontosan offer responses to basic needs for moist treatments, complex wounds and non-healing wounds, thus providing a novel approach to wound repair.
Regnier, internal marketing director of B Braun Medical (CoE Wound Care, France), said: “Silicone technology (Askina DresSil) provides a new standard of a traumatic wound care treatment whilst for infected wounds, the patented ionic silver alginate matrices (Askina Calgitrol Ag), provide a broad antimicrobial effectiveness and help to prevent contamination from external bacteria.”
Bussell, head of Centre of Excellence Infection Control (Prontosan), said: “The Wound Care symposium on Solutions for Problem Wounds will be chaired by Keith Harding (University of Cardiff, UK), who is joined by a team of acknowledged opinion leaders in wound care management including Gerit Mulder (University of California, US) and Wassim Raffoul (University of Lausanne, Switzerland).”
